Friday, February 17, 2023

Injection Pen Market Players, Size, Share, Analysis and Forecast-2030

Injection Pen Market

The worldwide injection pen market is predicted to grow at a CAGR of 6.9% with value of USD 73.3 billion during the forecast. 

The global injection pen market is mainly driven by the growing prevalence of chronic diseases requiring frequent injections and the growing awareness about the availability and benefits of injection pens over the conventional vial and syringe system. The report profiles the major factors affecting the global injection pen market to pinpoint the major drivers and restraints affecting the market and presents a detailed analysis of how the market is likely to grow over the forecast period.

The growing prevalence of chronic diseases such as diabetes and osteoporosis is likely to drive the global injection pen market over the forecast period. Insulin injections are a major application channel for the global injection pen market and are likely to retain their position as such over the forecast period due to the growing prevalence of diabetes and the immense advantages provided by injection pens in terms of managing the progression of diabetes. Diabetics require a regular administration of insulin injections, which can be cumbersome to handle with the conventional vial and syringe method. The conventional method also requires the patient to visit the hospital for each injection, which may be impractical for some patients. Using an injection pen makes it easier for diabetics to self-manage their disease, making this a key driver for the global injection pen market over the forecast period.

The growing product innovation in injection pens is also likely to be a major driver for the global injection pen market over the forecast period, as the technology to make injection pens safer and more effective is high in demand due to the growing popularity of injection pens. The growing efforts by manufacturers to make the most of the opportunity in the global injection pen market are likely to remain a key driver for the global injection pen market over the forecast period.

Major Key Players:

Some of the Injection Pen Market Players include Novo Nordisk, Sanofi, Ypsomed, F. Hoffman-La Roche, Owen Mumford, Pfizer, Jiangsu Delfu Medical Device Co. Ltd., Biocon Ltd., Haselmeier, Novartis, Becton Dickinson and Company, AstraZeneca, Merck, and Eli Lilly.

Segment Analysis

The global injection pen market is segmented on the basis of type, product, therapy, distribution channel, end user, and region.

On the basis of type, the injection pen market is classified into disposable injection pens and reusable injection pens.

The global injection pen market is segmented into insulin pens and pen needles on the basis of product.

On the basis of therapy, the injection pen market is segmented into diabetes, growth hormone therapy, fertility, osteoporosis, multiple sclerosis, cardiovascular diseases, rheumatoid arthritis, obesity, Crohn’s disease, cancer, diabetes injection pen and others. The diabetes segment is further segmented into insulin and GLP-1.

On the basis of distribution channel, the injection pen market is segmented into hospital pharmacies, retail pharmacies, online medical stores, and diabetes clinics.

On the basis of end user, the global injection pen market is segmented into home care and hospitals and clinics.

Regional Analysis

The global injection pen market is segmented by region into the Americas, Europe, Asia Pacific, and the Middle East and Africa.

The Americas is likely to remain the leading geographical segment of the global injection pen market over the forecast period due to the widespread adoption of injection pens and the growing popularity of injection pens in the healthcare sector. The growing presence of major market players in the U.S. and Canada is also conducive to steady growth of the injection market in the Americas.

Europe is also a major regional market for injection pen technology and is likely to remain a major revenue generator over the forecast period due to the growing economic burden of diabetes, which has driven the demand for more convenient and effective ways to manage diabetes. The advanced healthcare and medical devices sector in Europe is likely to be a major driver for the injection pen market in the region over the forecast period.

About Market Research Future

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 646 845 9312

Email: sales@marketresearchfuture.com

Thursday, February 16, 2023

Delirium Market – Industry Share Report 2022

Delirium Market

The Delirium Market is expected to reach USD 365.7 Million by 2030 at 5.70% CAGR during the forecast period 2022-2030.

Delirium is a neurological (nervous system) condition and is a serious disturbance in mental abilities that causes mental confusion and emotional disruption. Delirium can be caused due to various factors such as older age, exposure to certain medications, alcohol abuse, surgery or other medical procedures, factors such as exposure to toxic or infectious agents, physical trauma, diet, and behavioral and occupational factors.

Major Key Players:

Some of Delirium Market Players are Dr. Franz Kohler Chemie GmbH, Fraser Health, Gaia BioPharma Ltd., Novartis AG, Pfizer, Inc., Regenstrief Institute, Inc., and Air Liquide Sante International, among others.

Segment Analysis

The global delirium market is segmented on the basis of type, treatment, diagnosis, and end-user.

On the basis of type, the market is segmented into hyperactive, hypoactive, and mixed.

On the basis of diagnosis, the market is segmented into laboratory tests, imaging tests, and physical examination. On the basis of laboratory tests, it is further sub-segmented into blood tests and urine tests. On the basis of imaging tests, it is further sub-segmented into brain-imaging tests.

On the basis of treatment, the market is segmented into antipsychotics and supportive care. On the basis of treatment, antipsychotics is further sub-segmented into risperidone, olanzapine, and quetiapine.

On the basis of end-user, the market is segmented into specialty centers, hospitals, and research centers.

Regional Analysis

The Americas dominates the global delirium market owing to the increasing aging population and increasing rate of neurological conditions. Additionally, the increasing government initiatives and awareness programs are likely to enhance the growth of delirium in the North American region. Similarly, increasing government healthcare costs, along with the increasing awareness among population regarding mental health is expected to drive the growth of the delirium market in North America. For instance, iDelirium, a federation of 3 delirium societies (American Delirium Society, European Delirium Society, and Australasian Delirium Association) has launched various awareness programs across the country to spread awareness regarding delirium and its effects.

Europe accounts for the second largest market due to increasing aging mass and increasing neurological disorders. Additionally, the improving government funding and increasing healthcare infrastructure along with the increasing demand for technologically advanced treatment are driving the growth of delirium market in Europe. For instance, Eurostat estimated that over 19.2% of the population in Europe was aged 65 and above. This rising older population is likely to drive the growth of the delirium market.

Asia Pacific is the fastest growing market for delirium whose growth is attributed to the increasing population which in turn increases the overall patient population and rising population affected by post-surgical disorders. India and China are the primary contributors to the market growth due to the rising demand for advanced and newer treatments and rising development of healthcare infrastructure in these regions.

On the other hand, the Middle East and Africa is expected to witness a restricted growth due to limited access and affordability of the healthcare system and lack of awareness among individuals. In the Middle East, the growth of the market is driven by the growing awareness regarding neurological disorders and expanding healthcare scenario.

About Market Research Future

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 646 845 9312

Email: sales@marketresearchfuture.com

Artificial Eye Market Players, Size, Share, Synopsis & Forecast – 2030

Artificial Eye Market

The Artificial Eye Market is projected to reach USD 2,878.71 Million by 2030 at 7.10% CAGR during the forecast period 2022-2030.

Artificial eye is an ocular prosthesis that replaces an absent natural eye following an enucleation, evisceration, or orbital exenteration. It fits over an orbital implant and under the eyelids. Increasing number of visually impaired people worldwide has encourage many of the manufacturer for introduction of the new and better treatment for ophthalmic problems. According to WHO, the number of people suffering optic problem are increasing and approximately 90% of the patients are present in developing countries. Increasing number of people suffering from diabetes and rising geriatric population has driven the growth of the market. Beside this development in technology and increasing healthcare expenditure has provided fuel for the growth of the market. On the other hand, high cost, limited surgical professionals and availability of alternative therapy has hindered the growth of the market.

Major Key Players:

The Artificial Eye Market Players are Advanced Artificial Eye (US), The National Artificial Eye Services (NHS) (UK), Marie Allen Ocularist Ltd (Canada), COS-MEDIC PTY LTD (Australia), Retina Implant AG (Germany), Second Sight (US), Pixium Vision (France), Ericksons Custom Made Artificial Eye (Canada), International Prosthetic Eye Center (India)

Segment Analysis

Global artificial eye market is segmented on the basis of type, non-integrated implants, Integrated implants. Integrated implants are further segmented into hydroxyapatite, porous polyethylene, bioceramic, conical orbital implant and other. On the basis of technology, they are segmented into electronic and mechanical and on the basis of end user, the market is segmented into hospitals, ophthalmology clinics and others

Regional Analysis

On regional basis, global artificial eye market is segmented into four major regions namely Americas, Europe, Asia Pacific and Middle East and Africa.  

Because of its large geriatric population and growing number of people suffering from vision impairment, America leads the global artificial eye industry. According to the American Academy of Ophthalmology, more than a quarter of the population in the United States has a minor or major visual complication, and this figure is steadily increasing due to the growing diabetic population. Because of increased product innovation, increased presence of leading players, increased favorable reimbursement policies, and high acceptance of artificial eye surgeries in this area, North America dominates the artificial eye market. Due to the presence of qualified professionals, highly developed healthcare infrastructure, technological advances, and the presence of large market players in the region, the United States dominates the global artificial eye market. In addition, the country's large healthcare expenditures would drive business growth.

Because of increased construction activities, increased healthcare spending per person, and government support in this area, Europe has the second largest artificial eye market in terms of growth. The European artificial eye market will continue to be driven by rising demand for custom-made ocular prostheses and the the prevalence of ophthalmic diseases.

The artificial eye market in Asia Pacific is rising at the fastest pace. Because of their well-developed healthcare sectors and high health-care spending, Japan and Australia are the leading contributors to the industry. Because of technological advances, the disposable incomes, and the innovations in the healthcare system, Japan is expected to see substantial growth in the artificial eye market during the study era. Artificial eye demand will be boosted by the factors listed above.

Owing to a lack of medical services and weak economic and political conditions, the Middle East and Africa has the smallest market share. The artificial eye market in the Middle East and Africa is dominated by Saudi Arabia, the United Arab Emirates, and Kuwait.

About Market Research Future

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 646 845 9312

Email: sales@marketresearchfuture.com

Sentinel Node Biopsy Market - Global Industry Size, Share, Analysis and Forecast 2022 – 2030

Sentinel Node Biopsy Market

The global sentinel node biopsy market is growing pervasively mainly due to the increasing prevalence of various types of cancer including melanoma, colon cancer, breast cancer, esophageal cancer, head and neck cancer among others. Moreover, the spreading awareness towards the advantages of sentinel node biopsy escalates its market on the global platform.

The Sentinel Node Biopsy Market is projected to reach at 4.90% CAGR during the forecast period 2022-2030.

Additional factors propelling the growth of the market include the changing lifestyle led by the growing urbanization & industrialization. Improving economic conditions worldwide are defining the growth of the sentinel node biopsy market, enabling access to the quality of life & to the improved healthcare. Furthermore, factors such as increasing number of biopsy procedures and rising demand for new techniques for the diagnosis of cancerous growth provide significant impetus to the market growth.

On the other hand, factors such as prohibitive costs associated with the biopsy and the large unmet need are some of the key factors impeding the market growth, especially in the developing nations. Nevertheless, factors such as the availability of new products and services and the presence of well-established market players in the developing as well as developed countries will support the market growth, filling up the demand and supply gap.

Major Key Players:

Sentinel Node Biopsy Market Players include Devicor Medical Products, Inc. (Germany), C. R. Bard, Inc. (U.S.), Hilfe Engineering Corporation (India), Intramedical Imaging LLC (U.S.), KUB Technologies, Inc. (U.S.), Surgic Eye (Germany), and Navidea Biopharmaceuticals, Inc. (U.S.) among others.

Segment Analysis

The MRFR analysis is segmented into four key dynamics for enhanced understanding.

By Product          : Breast Localization Wire, Tissue Marker, Gamma Probe, and Drainage Catheters, liquid biopsy among others.

By Indication:  Breast Cancer, Melanoma, Colon Cancer, and Esophageal Cancer among others.

By End-user        : Hospitals & Clinics, and Diagnostic Centers among others.

By Regions          : North America, Asia Pacific, Europe, and the Rest-of-the-World.

Regional Analysis

The North American region, heading with the increasing number of market players offering biopsy devices and instruments, accounts for the leading market for sentinel node biopsy, globally. Factors such as the extensive and early uptake of medical technology for advancing medical devices and the increasing governmental support for R&D activities alongside the high health care expenditures substantiate the market growth in the region.

Furthermore, the increasing number of women suffering from breast disorders and rising prevalence of breast cancer along with the availability of quality care drives the growth of the regional market. With the constant developments by companies operating in cancer diagnostics, the market is expected to create the major revenue pocket during the review period.

The sentinel node biopsies market in the European region led by the increasing emphasis on the development of advent diagnostic devices, accounts for the next largest market, globally. Moreover, factors propelling the growth of the regional market include rising government support with the increased funding for R&D activities in the field of oncology and the rising numbers of specialty services offered by various healthcare providers.

Germany leads the European sentinel node biopsies market owing to an increasing demand for cancer diagnosis.  Whereas France and the U.K heading with the availability of tertiary care facilities in these countries and rising healthcare expenditures, secure second and third position, respectively.

The Asia Pacific region is emerging as a  profitable market for Sentinel Node biopsies, growing rapidly. Increasing incidents of breast cancer is a key driving factor fostering market growth.  Furthermore, factors such as the increasing demand for quality devices in healthcare and rapidly developing healthcare technology are fuelling the market growth in the APAC region, leading to increased use of advanced biopsy equipment.

India and China led by the presence of the highly skilled workforce and the increasing demand for biopsy procedures in hospitals and specialty care centers, exhibit enormous growth opportunities.  Moreover, growing occurrences of chronic diseases, an increase in the number of women suffering for reproductive disorders, and increasing expenditure on surgical procedures in developing economies throughout the APAC foster the growth of the regional market.

About Market Research Future

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 646 845 9312

Email: sales@marketresearchfuture.com

Lazy Eye Market Forecast to 2030 Available in New Report

Lazy Eye Market

The Lazy Eye Market is anticipated to reach USD 4,576.67 Million by 2030 at 5.20% CAGR during the forecast period 2022-2030.

Increasing prevalence of the lazy eye diseases, growing child population, rising healthcare expenditures, and increasing R&D by the major market players are estimated to be the major drivers governing the market growth during the forecast period. However, lack of awareness and unavailability of the effective treatment procedures may restrain the market growth during the projected period.

Major Key Players:

The Lazy Eye Market Players are inclusive of Pfizer Inc. (U.S.), TCI Chemicals (India) Pvt. Ltd. (India), Adwia Pharmaceuticals Co. (Egypt), 3M (U.S.), Bausch & Lomb Incorporated. (U.S.), Rebion (U.S.), Vivid Vision, Inc. (U.S.), Johnson and Johnson Services, Inc. (U.S.), and others.

Segment Analysis

The global lazy eye market is segmented on the basis of type, diagnosis, treatment, and end-user.

On the basis of the type, the market is segmented into strabismic amblyopia, refractive amblyopia, deprivation amblyopia, and others. On the basis of the diagnosis, the market is segmented into general eye test, squint test, and others. On the basis of the treatment, the market is segmented into corrective eyewear, eye patches, surgery, atropine eye drops, and others. The corrective eyewear segment is sub-segmented into glasses, contact lenses, and others. On the basis of the end-users, the market is segmented into eye care clinics, hospitals, retail pharmacies, and others.

Regional Analysis

The Americas lead the global lazy eye market. Presence of the well-developed healthcare sector, growing child population, and rising healthcare expenditure are the driving factors for the market growth. Additionally, the presence of the major players within the region boosts the market. Europe is estimated to be the second in the global lazy eye market owing to the availability of the funds for research and huge patient population. The Asia Pacific is the fastest growing region for the market. Developing healthcare sector and rising per capita healthcare expenditure are the major drivers of market growth within the region. The Middle East & Africa holds the least share in the lazy eye market owing to the poor availability of the healthcare services and low per capita healthcare expenditures within the African region. The Middle East region holds a majority of the market of the Middle East and Africa due to the presence of developed economies like Kuwait, Qatar, Dubai, Oman besides others. Moreover, the per capita healthcare expenditure within the region is high providing favorable backgrounds for market growth.

About Market Research Future

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 646 845 9312

Email: sales@marketresearchfuture.com

Vision Care Market Forecast to 2030 Detailed in New Research Report

Vision Care Market

Vision care plays an essential role in ophthalmology. The vision care products and procedures are used for treating the indications. For instance, the prevalence of vision impairment is about 1,000 million cases globally. The vision care has benefited resolve ophthalmic disorders and diseases.

Vision Care Market is expected to cross USD 237.05 Billion by 2030 at a CAGR of 4.03% during the forecast period 2022-2030

However, unawareness about the vision care products and services is likely to hamper the growth of the global vision care market during the forecast period.

Several market players currently dominate the global vision care market. The key players are involved in product launches and strategic collaborations to strengthen their market positions.

Major Key Players:

Some of the Vision Care Market Players are Cadila Healthcare (Zydus Pharmaceuticals, Inc.), Johnson & Johnson Services, Inc., Rayner Surgical Group Limited (Rayner Intraocular Lenses Limited), Menicon, Carl-Zeiss-Stiftung (Carl Zeiss). ESSILORLUXOTTICA, Bausch Health (Bausch & Lomb Incorporated), The Cooper Companies, Inc (Cooper Vision), NOVARTIS AG.

Segment Analysis

The global vision care market is segmented by product type, indication, treatment, and end-user.

The global vision care market based on product type is broadly segmented into a contact lens, eyeglasses, intraocular lens (IOL), contact lens solutions, and others.

Contact lenses are used as an aid to improve the physical make-up of a person and an alternative to glasses. Contact lenses are sub-segmented into the corrective lens, therapeutic lens, cosmetic, and lifestyle-oriented lens. These type of contact lenses are available as per the customization of color and design patterns along with the power of the lenses

Eyeglasses held the largest share in the global vision care market. This segment is further segmented into sunglasses, bifocal, single vision, and progressive.

By indication, it is segmented into glaucoma, diabetic retinopathy, refractive error, amblyopia, dry eyes, and others.

Refractive error held the largest share of the global vision care market in 2018. It is a condition of the eye wherein it cannot focus the images from the objects.

Diabetic retinopathy, on the other hand, is the fastest-growing segment owing to the rising prevalence of diabetes. For instance, in India the prevalence of diabetes is rising at faster rate and is expected to reach an alarming mark of about 69.9 million by the year 2025.

The global vision care market based on treatment is segmented into medication, surgery, and others. The surgery segment is estimated to have the largest share in the global vision care market. The surgery segment is sub-segmented into cataract surgery, cornea transplant, and vitrectomy. The high success rates of surgeries and efforts by eye care specialists to repair vision disorders can drive the segment growth rate. On the other hand, laser therapy is a non-invasive procedure and takes the least time compared to other procedures. This can drive its growth in the global eye care market till 2023.

The global vision care market based on end user is segmented into optical stores, eye hospitals & clinics, ambulatory surgery centers, and others. Eye hospitals and clinics hold the largest market share owing to the rising number of eye care hospitals and clinics. On the other hand, optical stores are the fastest-growing segment owing to the easy accessibility to vision care products and services and a large customer base.

Regional Analysis

The market has been divided, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa.

The Americas is anticipated to hold the largest market share owing to the increasing awareness about advanced vision care procedures. The vision care market is divided into the Americas has further been branched into North America and Latin America, with the North American market being divided into the US and Canada.

The vision care market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. Asia-Pacific is anticipated to hold the largest market share owing to the increasing number of increasing geriatric population and rising adoption of technological advancements in developing regions. The European vision care market has been categorized as Western Europe and Eastern Europe. The Western European market has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. The vision care market in the Middle East & Africa has been divided into the Middle East and Africa.

About Market Research Future

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 646 845 9312

Email: sales@marketresearchfuture.com

Sleeping Bruxism Treatment Market Report Predicts Impressive Growth by 2030 just published

Sleeping Bruxism Treatment Market

Sleep bruxism, which leads to grinding teeth at night, is a condition that can result in disturbed sleep, is an increasingly common condition. Reports that assess the healthcare industry have been presented by Market Research Future, which creates reports on numerous industry verticals that examine the market progress and forecasts. Sleeping Bruxism Treatment Market size is projected to be worth USD 934.90 million by 2030, registering a CAGR of 5.95% during the forecast period

The rising pediatric population and altering lifestyles are expected to motivate the sleeping bruxism treatment market globally. The increased accessibility to therapeutic medicines is projected to create an increased impetus for growth in the coming years. The enhanced quality in preventive measures for treating sleeping bruxism is expected to enhance the potential for growth in the approaching period.

Major Key Players:

The Sleeping Bruxism Treatment Market Players are Pfizer Inc. (U.S.), Ipsen Biopharmaceuticals, Inc. (U.S.), Henry Schein, Inc. (U.S.), Carestream Dental (U.S.), PLANMECA OY (Finland), Akervall Technologies Inc. (U.S.), Merz Pharma GmbH & Co. KGaA (Germany), Randmark Dental Products, LLC (U.S.), S4S Dental Laboratory (U.K.), Patterson Dental Supply, Inc. (U.S.), Ivoclar Vivadent AG (Liechtenstein), and others.

Segment Analysis

MRFR’s market study with regard to sleeping bruxism treatment covers segments like type, diagnosis, treatment type, cause, patient type, and end-user.

The main types considered in the market report include primary as well as secondary. The largest market in 2017 belonged to secondary bruxism, as a result of the surge in sleep disorders, rising intake of medicines that cause dental issues and evolving lifestyles in light of growing stress.

Treatment-wise, the key market categories can be dental approaches as well as medication. The dental approaches-based segments in the market are NTI-tss device and mouth guard. The medication-wise categories include Botox injections, anti-anxiety drugs and muscle relaxants.

The key causes of sleeping bruxism identified in the market study include sleep paralysis, obstructive sleep apnea, malocclusion, gastroesophageal reflux disease (GERD), and more. Between these, the obstructive sleep apnea category can touch USD 233.20 million by 2023, and also achieve an expansion rate of 7.0% during the given period.

Pediatric and adult remain the two patient type segments in the market. In the year 2017, the pediatric segment took the lead, as hyperactivity has become quite prevalent among children, in addition to anger issues, rising pain from teething and earache, and stress.

Some of the prominent end-users in the worldwide industry are dental clinics, hospitals, and others.

Regional Analysis

The Americas, the Middle East and Africa/MEA, Asia Pacific/APAC and Europe are the top markets for sleeping bruxism treatment.

The Americas, in 2017, measured up to a share of 39.1% in the sleeping bruxism treatment market. The key growth promoters include the escalating anxiety and stress among people and the significant surge in government spending on the target field. Mounting healthcare insurance among people also contributes to the expansion of the regional market. A few other factors encouraging market growth can be the rising introduction of innovative and advanced devices, and the burgeoning geriatric population in the region, especially in the United States, Mexico and Canada. 

Europe has procured the second position in the global market, due to the apparent surge in sleeping bruxism cases among children and adults alike. Strong economy, expanding dental awareness and high number of dental clinics aid significantly in the market growth in Europe. An expanding pool of patients suffering from snoring, irregular breathing and sleep disorders has also given a boost to sleeping bruxism, marking substantial market progress in the region.

With a steady advancement rate, the APAC market is largely backed by the rapid increase in the use of quality healthcare technology, fast economic growth and the massive population. Increasing spending on healthcare and the considerable expansion of the pediatric population also serves as catalysts in the market growth here. The growing knowledge level among people about sleep bruxism and the thriving dental industry in India, Japan, South Korea and China also bolster the market demand in APAC.

About Market Research Future

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 646 845 9312

Email: sales@marketresearchfuture.com

Artificial Insemination Market Players, Share, Size, Trend, SWOT Analysis and Forecast to 2030

Artificial Insemination Market The artificial Insemination market   is expected to reach USD 8.9 billion by 2030 at CAGR of 8.6% during t...